MB "Biogamyba" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
Financial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
0 |
0 |
-10,269 |
-10,269 |
-10,269 |
- |
- |
-7,913 |
9,437 |
264 |
1,260 |
2022 |
---|
62,502 |
22,164 |
14,818 |
14,818 |
5,255 |
74.48 |
23.71 |
6,617 |
22,830 |
18,805 |
10,642 |
2023 |
---|
140,130 |
30,798 |
20,171 |
18,754 |
4,122 |
39.89 |
13.38 |
25,370 |
103,825 |
16,755 |
112,440 |
Register and
explore Okredo data2023 |
---|
140,130 |
30,798 |
20,171 |
18,754 |
4,122 |
39.89 |
13.38 |
25,370 |
103,825 |
16,755 |
112,440 |
Register and
explore Okredo data2023
Turnover (€)
140,130 €124 % *
Sales per employee (€)
30,798 €39 % *
Profit before tax (€)
20,171 €36 % *
Net Profit (€)
18,754 €27 % *
Profit per employee (€)
4,122 €-22 % *
Total profitability (%)
39.89 %-46.44 % *
Net profitability (%)
13.38 %-43.57 % *
Equity (€)
25,370 €283 % *
Amounts Payable And Liabilities (€)
103,825 €355 % *
Non-current Assets (€)
16,755 €-11 % *
CurrentAssets (€)
112,440 €957 % *